Airain Ltd’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$422K Sell
15,235
-360,716
-96% -$9.57M 0.02% 576
2017
Q1
$9.35M Sell
375,951
-1,863
-0.5% -$45.3K 0.46% 59
2016
Q4
$8.17M Sell
377,814
-203,933
-35% -$4.45M 0.66% 38
2016
Q3
$13.8M Buy
581,747
+390,211
+204% +$9.31M 0.82% 20
2016
Q2
$4.48M Buy
+191,536
New +$4.14M 0.26% 116
2016
Q1
Sell
-225,347
Closed -$4.16M 813
2015
Q4
$4.16M Buy
225,347
+98,778
+78% +$1.77M 0.29% 86
2015
Q3
$2.08M Buy
+126,569
New +$2.16M 0.12% 219
2015
Q1
Sell
-705,319
Closed -$9.35M 831
2014
Q4
$9.35M Buy
705,319
+276,828
+65% +$3.54M 0.77% 23
2014
Q3
$5.06M Buy
428,491
+297,415
+227% +$3.75M 0.34% 76
2014
Q2
$1.67M Sell
131,076
-4,515
-3% -$58.7K 0.14% 169
2014
Q1
$1.83M Buy
+135,591
New +$1.78M 0.32% 86

Other funds holding BSX

Airain Ltd's BSX Position: Q2 2017 in Review

Airain Ltd reduced its Boston Scientific (BSX) stake by 96% in Q2 2017, selling an estimated $9.57M and leaving 15,235 shares worth $422K. The position accounts for 0.02% of the portfolio, ranked #576.

Airain Ltd first reported a position in BSX in Q1 2014 and has held it in 11 quarters since. The position peaked at $13.8M in Q3 2016. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

  • Airain Ltd held 15,235 shares of Boston Scientific worth $422K as of Q2 2017.
  • Airain Ltd sold 360,716 Boston Scientific shares in Q2 2017, an estimated $9.57M.
  • Boston Scientific made up 0.02% of Airain Ltd's portfolio in Q2 2017, its #576 holding.
  • Airain Ltd first reported a position in Boston Scientific in Q1 2014 and has held it in 11 quarters since.
  • Airain Ltd's Boston Scientific position peaked at $13.8M in Q3 2016.
  • 558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.